High-Quality Manufacture
Active pharmaceutical ingredients (API) must meet the highest de-mands regarding their quality before they are prescribed for the patient. This is a must; from the first up to the last production step. With our plants we contribute world-wide to the high level of reliability, exactness of composition and reproducibility you require from your pharmaceutical products. Be it the manufacture of injection solutions, the provision and storage of buffer solutions, the processing of aerosols or the generation and distribution of pure media - which are only some examples.
Sophisticated Solutions
A plant is more than the sum of its parts because all equipment must comply with each other. A solution that is thoroughly planned is vital for the manufacture and processing of pharmaceutical drugs; only then you can be sure that you get the product you want. Whether it is the perfect cleaning of the vessel, the skilful pipeline layout, the design and type of valves, heat exchangers and measuring instruments or the development of a comprehensive design concept including basic and detail engineering as well as execution, documentation and qualification - we are ready for you and your project team.
All Production Steps from One Source
As specialist for complete plants for the pharmaceutical industry GEA Diessel offers the full service for every requirements and every need: from the design, development and installation of your new process plant up to qualification and maintenance work - together with your project team our experienced process engineers are able to develop innovative and efficient process technologies for your very specific applications.
Examples for process plants realized by GEA Diessel:
| Product |
Production Plant |
| Cough Syrup |
Syrup |
| Stomach Medicine |
Suspension |
| Infusions; Injectables |
Parenterals |
| Aerosols,Echo Contrast |
Special Liquids |
| Eye, Ear,Nasal drops |
Drip and drop solutions |
For detailed information please refer to our brochure "Process plant for pharmaceutical and biotechnology industries".